China's Tobacco Exports Surge in 2023, Showing Impressive Growth

Market by 2FIRSTS Mincy
Jan.30.2024
China's Tobacco Exports Surge in 2023, Showing Impressive Growth
China's tobacco export reached a total of $9.17 billion in 2023, a 22.2% increase compared to the previous year.

According to data released by the General Administration of Customs, China's tobacco exports experienced robust growth in 2023, reaching a total value of $9.173 billion, representing a year-on-year increase of 22.2%. When calculated in terms of Chinese yuan, the value reached 64.595 billion yuan, marking a year-on-year growth of 28.33%.

China's Tobacco Exports Surge in 2023, Showing Impressive Growth
Mapping: 2FIRSTS (Mincy)

 

According to specific subcategory data, the export revenue for roasted tobacco amounted to $382 million, a decrease of 14.61% compared to the previous year. In terms of the Chinese currency, it was valued at 2.683 billion yuan, a decrease of 9.75% year-on-year. On the other hand, the export revenue for rolled cigarettes reached $280 million, showing a substantial growth of 106.47% compared to the previous year. In terms of the Chinese currency, it was valued at 1.984 billion yuan, an impressive increase of 116.53% year-on-year.

China's Tobacco Exports Surge in 2023, Showing Impressive Growth
Chart: 2FIRSTS (Mincy)

 

Taking into account the weight criteria, the export of flue-cured tobacco in 2023 is estimated to be around 100,000 tons, marking a YoY decrease of 28.17%. In contrast, the export weight of cigarettes is 19,400 tons, showing a YoY increase of 44.01%. Moreover, the number of cigarette sticks exported reached 83.92 million, indicating a growth of 36.62% compared to the previous year.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Research Summary | NHANES Study: Smoking or E-Cigarette Use Linked to Higher Prevalence of Elevated Blood Pressure and Hypertension
Research Summary | NHANES Study: Smoking or E-Cigarette Use Linked to Higher Prevalence of Elevated Blood Pressure and Hypertension
A cross-sectional analysis based on the US NHANES 2021–2023 cycle, including 6,262 participants aged over 12, found that compared with people who neither smoke nor vape, those who smoke and/or use e-cigarettes had a higher prevalence of elevated blood pressure and hypertension. After full adjustment, smoking/vaping was associated with elevated blood pressure (aOR 1.34) and hypertension (aOR 1.46), and with a 1.05 mmHg higher diastolic blood pressure.
Feb.09 by 2FIRSTS.ai
Belgium seizes 140,019 disposable vapes since the start of 2025 after sales ban took effect
Belgium seizes 140,019 disposable vapes since the start of 2025 after sales ban took effect
Belgium’s Federal Public Health Service said it has seized 140,019 disposable vapes since the start of 2025. The crackdown follows a ban on the sale of disposable e-cigarettes that came into force on January 1.
Dec.31 by 2FIRSTS.ai
Estonia warns of a booming illicit vape market, raising risks for minors and legitimate trade
Estonia warns of a booming illicit vape market, raising risks for minors and legitimate trade
Estonia’s Chamber of Commerce and Industry and the Tax and Customs Board are urging the government to address a thriving illicit vape market that undermines fair competition and makes vapes easily accessible to minors.
Feb.04 by 2FIRSTS.ai
PMI’s Japan unit to raise IQOS ILUMA stick prices; TEREA and SENTIA to increase from April
PMI’s Japan unit to raise IQOS ILUMA stick prices; TEREA and SENTIA to increase from April
Japan will adjust tobacco taxes from April 1, 2026, prompting Philip Morris International (PMI) to lift prices for its IQOS ILUMA tobacco sticks TEREA and SENTIA. Both products are set to rise by 40 yen per pack (about $0.3).
Jan.21 by 2FIRSTS.ai
TGA Sets 2026–2027 Compliance Principles, Flags Vaping Goods as a 2026 Priority
TGA Sets 2026–2027 Compliance Principles, Flags Vaping Goods as a 2026 Priority
The Therapeutic Goods Administration (TGA) has released its Compliance Principles for 2026 and 2027.Among 12 therapeutic goods categories identified for priority compliance and enforcement activity, TGA includes vaping goods, and it plans a further review of these priorities in March 2026.
Jan.23 by 2FIRSTS.ai
Nicotine Becomes Second-Largest Revenue Source for Couche-Tard in Fiscal 2025
Nicotine Becomes Second-Largest Revenue Source for Couche-Tard in Fiscal 2025
Alimentation Couche-Tard reported that nicotine products accounted for 9% of total revenue in fiscal 2025, making it the company’s second-largest revenue source after fuel, according to its latest Business Strategy Update.
Market
Feb.19